Kentsun Medipharma Co., Ltd.
Kentsun Medipharma Co., Ltd.
🇨🇳 China, Guangdong
200411-50 peopleManufacturer/Trading CompanyKentsun Medipharma Co., Ltd. is a manufacturer and trading company based in Guangzhou, China, established in 2001. With 11 to 50 employees, the company specializes in a diverse range of products across the medical, pharmaceutical, and chemical sectors. Their core offerings include anti-malaria drugs such as artemisinin, artesunate, and artemether API, as well as other pharmaceutical APIs, chemicals, and food additives. In the medical device sector, Kentsun Medipharma manufactures and trades dental chair units, various other dental products, and general medical equipment, including air compressors and plaster model trimmers. The company operates a factory and engages in international trade, serving both manufacturing and trading functions for its product lines.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Established brandFounded in 2004, with over 20 years of industry experience.
Contact
*************
2
Products
Products
0
Categories
0
Air Compressor
0·0 reviews
Dental Chair
0·0 reviews
Plaster Model Trimmer (SM-10)
0·0 reviews
Ask AI about this supplier
Similar suppliers you may like
Pharmaceutical Joint Stock Company 3/2
🇻🇳 Vietnam
1976501-1000 peopleManufacturer/Trading Company/Wholesaler/DistributorHigh capacity factory
Established brand
OEM manufacturer
Own brand
Key customer
7 ELEVEN
Key market
🇸🇬 Singapore
Description
Pharmaceutical Joint Stock Company 3/2, also known as F.T.PHARMA, is a prominent Vietnamese pharmaceutical manufacturer and distributor with over 44 years of industry experience. Founded in 1976 and headquartered in Ho Chi Minh City, the company has evolved into a key subsidiary of Japan's Zeria Pharmaceutical Group, which holds a majority stake. The company operates a large-scale business employing between 501 and 1000 professionals and maintains a robust distribution network serving hospitals, clinics, and major pharmacy chains such as Pharmacity and Long Chau.
BROMHEXIN 4mg
BISOPROLOL 5
BISOPROLOL 2,5
BEDOUZA 1000
BĂNG ĐÔ PHẪU THUẬT
BÀN CHẢI VỆ SINH KÊNH TÁI SỬ DỤNG
BÀN CHẢI TAY/ MÓNG TAY
BÀN CHẢI ỐNG MỞ KHÍ QUẢN
AKFEDIN 60
AKFEDIN 180
AKFEDIN 120
ADAZOL
Imexpharm Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
19771001-2000 peopleManufacturer/DistributorHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
27
Key customer
BURYAT OMBOL
Key market
Europe
Description
Imexpharm Pharmaceutical Joint Stock Company is a premier Vietnamese pharmaceutical manufacturer and distributor with over 48 years of industry experience. Headquartered in Cao Lanh, the company operates four major manufacturing clusters across Dong Thap, Ho Chi Minh City, and Binh Duong. Imexpharm is a leader in high-tech pharmaceutical production, maintaining 11 production lines that meet stringent EU-GMP standards, alongside WHO-GMP, GMP-ASEAN, and ISO 9001:2015 certifications. The company employs between 1,001 and 2,000 professionals and maintains a robust distribution network of 20 sales branches nationwide.
Specializing in both the Ethical (ETC) and Over-the-Counter (OTC) channels, Imexpharm is the leading domestic brand in the Vietnamese antibiotics market. Its extensive product portfolio includes Penicillins, Cephalosporins, and injectable antibiotics produced using advanced enzymatic technology. Beyond antibiotics, the company manufactures a wide range of therapeutic solutions for cardiovascular health, diabetes, musculoskeletal conditions, respiratory systems, and digestive health, as well as vitamins and health supplements. Their dosage forms include lyophilized injections, dispersible tablets, hard capsules, and oral suspensions.
As a key player in international trade, Imexpharm has successfully registered 28 Market Authorization Units (MAUs) in Europe, demonstrating its capability to meet global quality benchmarks. The company provides contract manufacturing and OEM services, collaborating with multinational partners such as Sandoz, Sanofi-Aventis, and Pharmacience Canada. Backed by strategic investment from South Korea's SK Group, Imexpharm continues to expand its R&D capabilities and non-antibiotic product lines to serve both domestic healthcare needs and international export markets.
Thực Phẩm Bảo Vệ Sức Khỏe
Vitamin & khoáng chất
Nhóm dùng ngoài
Diệt trừ ký sinh trùng
Tiểu đường
Tiêu hóa gan mật
Giãn mạch ngoại biên và hoạt hóa não
Kháng Histamin & Kháng dị ứng
Hệ hô hấp
Giảm đau - kháng viêm - hạ sốt
Cơ xương khớp
Mắt
